ORAGENICS, INC. Shareholders' Equity
ORAGENICS, INC. (OGEN) had Shareholders' Equity of $3.67 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $3.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.18M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $8.28M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.83M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $3.67M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $6.18M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $8.28M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $9.83M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | -$2.13M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $137.69K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | -$211.88K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $3.08M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $1.33M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $2.63M 10-Q · filed 2025-11-07 | $2.63M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.17M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $6.50M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $7.26M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $10.24M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $13.01M 10-K · filed 2025-03-14 | |
| 2022-09-30 | $15.27M 10-Q · filed 2023-11-09 | $13.34M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $18.67M 10-Q · filed 2023-11-09 | $16.79M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $21.99M 10-Q · filed 2023-11-09 | $20.54M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $26.49M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $28.55M 10-Q/A · filed 2023-04-14 | |
| 2021-06-30 | $32.73M 10-Q/A · filed 2023-04-14 | |
| 2021-03-31 | $36.05M 10-Q/A · filed 2023-04-14 | |
| 2020-12-31 | $16.84M 10-K · filed 2023-04-17 | |
| 2020-09-30 | $9.64M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $8.79M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $12.91M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $17.23M 10-K/A · filed 2022-07-29 | |
| 2019-09-30 | $20.82M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $24.42M 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $29.12M 10-Q · filed 2020-11-10 | |
| 2018-12-31 | $20.88M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $13.98M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $3.65M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | $4.32M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $6.32M 10-K · filed 2020-03-04 | |
| 2017-09-30 | $1.01M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $505.49K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.19M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $2.97M 10-K · filed 2019-03-29 | |
| 2016-09-30 | $4.49M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.24M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $2.87M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $4.73M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $1.50M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $3.09M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $9.16M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $10.34M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $11.56M 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $12.56M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $14.20M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $15.84M 10-K · filed 2016-03-30 | |
| 2013-09-30 | $4.36M 10-Q · filed 2013-10-25 | |
| 2013-06-30 | $5.68M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $7.65M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $9.23M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $10.83M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$1.45M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | -$314.25K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$8.18M 10-K · filed 2014-02-28 | |
| 2011-09-30 | -$6.58M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$4.99M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | -$1.90M 10-K · filed 2013-03-26 | |
| 2009-12-31 | $2.64M 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |